Cost-Effectiveness of Colonoscopy

le Zauber, Ann G.
Foilsithe 2010

The Impact of Screening on Colorectal Cancer Mortality and Incidence – Has It Really Made a Difference?

le Zauber, Ann G.
Foilsithe in Dig Dis Sci (2015)

Colorectal cancer screening: Now is the time

le Winawer, Sidney J., Zauber, Ann G.
Foilsithe 2000

Screening for colorectal cancer

le Winawer, Sidney J., Zauber, Ann G.
Foilsithe 2001

Simulation of Colorectal Cancer Screening: What We Do and Don’t Know and Does It Matter

le van Ballegooijen, Marjolein, Boer, Rob, Zauber, Ann G.
Foilsithe 2010

Colorectal Cancer Health Disparities and the Role of US Law and Health Policy

le DOUBENI, CHYKE A., CORLEY, DOUGLAS A., ZAUBER, ANN G.
Foilsithe in Gastroenterology (2016)

The Influence of UGT 1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma

le Chan, Andrew T., Hsu, Meier, Zauber, Ann G., Hawk, Ernest T., Bertagnolli, Monica M.
Foilsithe 2011

Statin Use and Colorectal Adenoma Risk: Results from the Adenoma Prevention with Celecoxib (APC) Trial

le Bertagnolli, Monica M., Hsu, Meier, Hawk, Ernest T., Eagle, Craig J., Zauber, Ann G.
Foilsithe 2010

Multicohort Models in Cost-Effectiveness Analysis: Why Aggregating Estimates over Multiple Cohorts Can Hide Useful Information

le O’Mahony, James F., van Rosmalen, Joost, Zauber, Ann G., van Ballegooijen, Marjolein
Foilsithe 2012

Cost-effectiveness of surveillance with CT colonography after resection of colorectal cancer

le Kuntz, Karen M, Popp, Jonah, Beck, J Robert, Zauber, Ann G, Weinberg, David S
Foilsithe in BMJ Open Gastroenterol (2020)

C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment

le Chan, Andrew T., Sima, Camelia S., Zauber, Ann G., Ridker, Paul M, Hawk, Ernest T., Bertagnolli, Monica M.
Foilsithe 2011

The National Polyp Study at 40: challenges then and now

le Winawer, Sidney J., Zauber, Ann G., O’Brien, Michael J., Geenen, Joseph, Waye, Jerome D.
Foilsithe in Gastrointest Endosc (2020)

Effect of Rising Chemotherapy Costs on the Cost Savings of Colorectal Cancer Screening

le Lansdorp-Vogelaar, Iris, van Ballegooijen, Marjolein, Zauber, Ann G., Habbema, J. Dik F., Kuipers, Ernst J.
Foilsithe 2009

Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force

le Zauber, Ann G., Lansdorp-Vogelaar, Iris, Knudsen, Amy B., Wilschut, Janneke, van Ballegooijen, Marjolein, Kuntz, Karen M.
Foilsithe 2008

Contribution of screening and survival differences to racial disparities in colorectal cancer rates

le Lansdorp-Vogelaar, Iris, Kuntz, Karen M., Knudsen, Amy B., van Ballegooijen, Marjolein, Zauber, Ann G., Jemal, Ahmedin
Foilsithe 2012

The Appropriateness of More Intensive Colonoscopy Screening than Recommended in Medicare Beneficiaries: A Modeling Study

le van Hees, Frank, Zauber, Ann G., Klabunde, Carrie N., Goede, S. Luuk, Lansdorp-Vogelaar, Iris, van Ballegooijen, Marjolein
Foilsithe in JAMA Intern Med (2014)

Evaluation of the Effectiveness and Cost-Effectiveness of Personalized Surveillance After Colorectal Adenomatous Polypectomy

le McFerran, Ethna, O'Mahony, James F, Fallis, Richard, McVicar, Duncan, Zauber, Ann G, Kee, Frank
Foilsithe in Epidemiol Rev (2017)

Higher versus Lower Intensity Surveillance for Patients with Colorectal Adenomas: A Cost-Effectiveness Analysis

le Meester, Reinier G.S., Lansdorp-Vogelaar, Iris, Winawer, Sidney J., Zauber, Ann G., Knudsen, Amy B., Ladabaum, Uri
Foilsithe in Ann Intern Med (2019)

Risk of endometrial cancer in relation to medical conditions and medication use

le Fortuny, Joan, Sima, Camelia, Bayuga, Sharon, Wilcox, Homer, Pulick, Katherine, Faulkner, Shameka, Zauber, Ann G., Olson, Sara H.
Foilsithe 2009

Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population: A Cost-Effectiveness Analysis

le Lansdorp-Vogelaar, Iris, Kuntz, Karen M., Knudsen, Amy B., Wilschut, Janneke A., Zauber, Ann G., van Ballegooijen, Marjolein
Foilsithe 2010